Sign In
Buy ABBV
$227.23
+2.30 (+1.02%)
At Close: Jun 05, 2026
7 ‘Bulletproof' Stocks to Buy Ahead of a Wild New Year
06:54pm, Tuesday, 19'th Dec 2023
Although a new year tends to bring optimism in the market, current vagaries warrant a discussion about bulletproof stocks to buy for 2024. To be fair, even the most influential voices in government ar
Dividend kings: Which stocks continued to increase payouts in 2023?
10:56am, Tuesday, 19'th Dec 2023
Dividend stocks have always been and will be, among the most compelling choices for investors seeking stable and enduring returns.
Stock(ing) Stuffers That Could Be Lovin the High 2024
10:34am, Tuesday, 19'th Dec 2023
Just for the fun of it and since we did not include it in our Outlook 2024, I decided to have a look at what experts are saying concerning mushrooms, cannabis, and hemp. After all, recreational and me
7 Dividend Stocks to Buy as Bond Yields Fall
01:35pm, Monday, 18'th Dec 2023
Colgate-Palmolive, Amgen, and others have solid records of increasing dividend payments.
3 Biotech Stocks Most Wall Street Analysts Are Bullish About
10:31am, Monday, 18'th Dec 2023
Here we present three biotech stocks, CRSP, ITCI and DVAX, which most analysts on Wall Street are optimistic about. These companies have upside potential for 2024, backed by strong fundamentals.
Better Income Stock: AT&T or AbbVie?
03:30pm, Sunday, 17'th Dec 2023
Dividend stocks can be powerful components of a well-diversified income portfolio. AT&T and AbbVie are two popular blue chip dividend stocks known for their high yields.
3 of the Most Attractive Dividend Stocks in the Pharma Space
02:00pm, Sunday, 17'th Dec 2023
In the realm of investment, pharma dividend stocks are a beacon for both stability and growth. This sector not only enhances the quality of life on a global scale but also presents lucrative opportuni
Dividend Income Update November 2023
11:10pm, Friday, 15'th Dec 2023
With the markets at or near all time highs, after a wild up and down 2023, I could find comfort in one thing, my dividends. As we all know, the market may move up and down irrationally and seemingly o
AbbVie (ABBV) Declines More Than Market: Some Information for Investors
06:47pm, Friday, 15'th Dec 2023
In the latest trading session, AbbVie (ABBV) closed at $154.04, marking a -0.54% move from the previous day.
Wells Fargo's top pharma picks for 2024
05:33pm, Friday, 15'th Dec 2023
Mohit Bansal, Wells Fargo Analyst, joins 'Closing Bell: Overtime' to discuss Wells Fargo's pharma picks for 2024.
5 Dividend Aristocrats Signal Buy In December, With 6 To Watch
02:10pm, Thursday, 14'th Dec 2023
"Dividend Aristocrats in the S&P 500 Index have raised their annual payouts every year for at least 25 consecutive years. "--Kiplinger.com/Investing. 66 Aristocrats, screened as of December 12, 2023,
The 7 Most Undervalued Growth Stocks to Buy in December
04:42pm, Wednesday, 13'th Dec 2023
Stocks of a lot of well-known and historically great companies are on sale right now. Many marquee names haven't shared in this year's market rally and are in the red for 2023.
Economic Safety Nets: 7 Defensive Stocks Providing Portfolio Stability
08:44am, Wednesday, 13'th Dec 2023
Although investors have some evidence of a possible economic recovery, they should still consider defensive stock picks. We just don't know what will happen next.
AbbVie Just Followed Pfizer's Big Move. Here's What It Means For Investors
10:15am, Tuesday, 12'th Dec 2023
AbbVie is buying ImmunoGen to pocket its antibody drug conjugate (ADC) assets. Pfizer just did the same thing with Seagen on a much larger scale.
AbbVie continues shopping spree with biotech buyout
08:56am, Tuesday, 12'th Dec 2023
Last week, AbbVie announced a plan to acquire the Massachusetts-based biotechnology company in an all-cash deal worth $8.7 billion. Cerevel, which specializes in treatments for brain diseases, finishe
